Published
Digital Health Products and Their Regulatory Challenges
Published in March 2026 Issue 03 (Vol. 14, Issue 3, 2026)

Abstract
Mobile health applications, wearable devices, telehealth platforms, artificial intelligence (AI) applications, and electronic health records have changed healthcare delivery through improving access, efficiency, and participation of patients. Regulatory affairs will have an essential part in assuring the safety, effectiveness, quality, and data security of digital health innovations as they expand and grow fast. By influencing how we classify products, evaluate risk, clinically validate, secure cybersecurity, improve interoperability, and evaluate post-market regulatory pathways, we seek to find a balance between innovation and patient safety.
Keywords: Artificial Intelligence (AI), Mobile Health, Quality Assurance
Authors (2)
Shubham.S.Wadate
YSPM’s YTC Faculty of Pharmacy...YSPM’s YTC Faculty of Pharmacy, SataraYSPM’s YTC Faculty of Pharmacy, SataraYSPM’s YTC Faculty of Pharmacy, Satara
View all publications →Aneri.V.Adsul
YSPM’s YTC Faculty of Pharmacy...YSPM’s YTC Faculty of Pharmacy, SataraYSPM’s YTC Faculty of Pharmacy, SataraYSPM’s YTC Faculty of Pharmacy, Satara
View all publications →Download Article
DOCX
DOCX
Best for printing and citation
File size: 0.1 MB
Format: DOCX
Download Article
DOCX
DOCX
Best for printing and citation
File size: 0.1 MB
Format: DOCX
Article Information
Published in:
March 2026 Issue 03 (Vol. 14, Issue 3, 2026)AJPHR3140002
AJPHR-91-000006
19-28
2026-03-20
Article Impact
Views:5,869
Downloads:1,873
How to Cite
Shubham.S.Wadate & Aneri.V.Adsul (2026). Digital Health Products and Their Regulatory Challenges. American Journal of Pharmacy and Health Research, 14(3), 19-28. https://ajphr.com/articles/AJPHR3140002
Article Actions
More from this Issue
A case of Pericardial Effusion in Patient with Hypertension and CKD Grade-V.
Nishant Kumar, Anshu Kuma...Read more →
